Home > Balance Sheet > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
Contingent Liabilities

    Back to Balance Sheet
GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLAXOSMITHKLINE PHARMACEUTICALS
Please provide your vote to see the results

GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Contingent Liabilities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Contingent Liabilities ₹515 Cr₹456 Cr₹387 Cr₹354 Cr₹355 Cr

What is the latest Contingent Liabilities ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?

The latest Contingent Liabilities ratio of GLAXOSMITHKLINE PHARMACEUTICALS is ₹515 Cr based on Mar2026 Consolidated results.
Year Contingent Liabilities
Mar2026₹515 Cr
Mar2025₹456 Cr
Mar2024₹387 Cr
Mar2023₹354 Cr
Mar2022₹355 Cr

How is Contingent Liabilities of GLAXOSMITHKLINE PHARMACEUTICALS Trending?

Years Contingent Liabilities % Change
Mar2026 ₹515 Cr
12.92
Mar2025 ₹456 Cr
17.78
Mar2024 ₹387 Cr
9.46
Mar2023 ₹354 Cr
-0.26
Mar2022 ₹355 Cr -

Compare Contingent Liabilities of peers of GLAXOSMITHKLINE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS ₹46,185.2 Cr 7% 6.7% -4.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹454,914.0 Cr 7.3% 8.4% 13.1% Stock Analytics
DIVIS LABORATORIES ₹300,380.0 Cr 15.3% 24.1% 63% Stock Analytics
TORRENT PHARMACEUTICALS ₹181,169.0 Cr 1% 2.5% 33.4% Stock Analytics
DR REDDYS LABORATORIES ₹114,933.0 Cr 1% 15.9% 14% Stock Analytics
CIPLA ₹114,478.0 Cr 0.4% 7.9% -6.2% Stock Analytics


GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS

7%

6.7%

-4.6%

SENSEX

5.5%

13.3%

-3.4%


You may also like the below Video Courses